# Measuring Growth and Evaluating Pubertal Development in Pediatric Clinical Trials; Draft Guidance for Industry; Availability - FDA Guidance Document Source: https://www.globalkeysolutions.net/guidances/guidance-document/measuring-growth-and-evaluating-pubertal-development-in-pediatric-clinical-trials-draft-guidance-for-industry-availability/b3766e09-0a47-4099-a69c-f48ac2979eb8 > FDA guidance document: Measuring Growth and Evaluating Pubertal Development in Pediatric Clinical Trials; Draft Guidance for Industry; Availability. Issue date: October 31, 2022. Get complete insights and analysis. --- ## Details - Title: Measuring Growth and Evaluating Pubertal Development in Pediatric Clinical Trials; Draft Guidance for Industry; Availability - Communication Type: Guidance Document - Product Type: drugs - Office Name: Center for Drug Evaluation and Research - Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c - Issue Date: 2022-10-31 - Comment Close Date: 2023-01-03 - Last Changed: 2024-04-11 - Docket Number: FDA-2022-D-0760 ## Related Documents - [Pediatric Drug Development Under the Pediatric Research Equity Act and the Best Pharmaceuticals for Children Act: Scientific Considerations](https://www.globalkeysolutions.net/guidances/guidance-document/pediatric-drug-development-under-the-pediatric-research-equity-act-and-the-best-pharmaceuticals-for-children-act-scientific-considerations/ec636095-c1f7-4772-8dae-ff1ea7ee80fc) - [Early Alzheimer’s Disease: Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/early-alzheimers-disease-developing-drugs-for-treatment/ef0ff9a7-7208-4951-acbb-acb9937f83e7) - [Pregnant Women: Scientific and Ethical Considerations for Inclusion in Clinical Trials](https://www.globalkeysolutions.net/guidances/guidance-document/pregnant-women-scientific-and-ethical-considerations-for-inclusion-in-clinical-trials/674ff9d8-e752-4113-b7fd-bc85b7646bd3)